REGN
NASDAQStockRegeneron Pharmaceuticals, Inc.
$750.03-24.29 (-3.13%)
52-Week Range
$483.07
$812.27
Key Stats
Market Cap
77.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.40
Volume
377.8K
Avg Volume
633.8K
Performance
1M
-4.15%
3M
-0.80%
6M
+30.39%
YTD
-3.83%
1Y
+9.70%
3Y
-2.63%
5Y
+54.28%
Price Chart
ETF Exposure
REGN is held by 381 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SCHJ | Schwab 1-5 Year Corporate Bond ETF | 0.04% |
| LCTU | iShares U.S. Carbon Transition Readiness Aware Active ETF | 0.04% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.03% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.03% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.03% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.03% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.03% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.03% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.03% |
| SPXL | Direxion Daily S&P 500 Bull 3X ETF | 0.03% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.03% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.03% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.03% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.02% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.02% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.02% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.02% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.01% |
| IRTR | iShares LifePath Retirement ETF | 0.01% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.01% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.01% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.01% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.01% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.01% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.01% |
| SCHZ | Schwab U.S. Aggregate Bond ETF | 0.01% |
| GEW | Cambria Global EW ETF | 0.00% |
| BBAG | JPMorgan BetaBuilders U.S. Aggregate Bond ETF | 0.00% |
| IQSU | NYLI Candriam U.S. Large Cap Equity ETF | 0.00% |
| LRND | NYLI U.S. Large Cap R&D Leaders ETF | 0.00% |
| WRND | NYLI Global Equity R&D Leaders ETF | 0.00% |
PreviousPage 8 of 8
About REGN ETF Exposure
Regeneron Pharmaceuticals, Inc. (REGN) is held by 381 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 77.9B, REGN is a widely held institutional stock. The stock currently trades at $750.03. Investors can gain exposure to REGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold REGN, sorted by portfolio weight.